India-first daily coverage of GLP-1 therapy — DCGI approvals, Indian generic launches (Sundae, Noveltreat, Obeda, Semabest…), price cuts, Mounjaro / tirzepatide updates, and trial readouts (STEP, SUSTAIN, SURMOUNT, SELECT).
Weight Loss Drugs: Doctors Warn Against Panic Rediff
Indian drugmakers take generic semaglutide battle to overseas markets Business Standard
Florence Pugh slams body shaming, denies Ozempic use says ‘never done any face surgery’ The Hawk
Florence Pugh slams claims of Ozempic use and cosmetic surgery, says online scrutiny of her body is disturbing India TV News
Semaglutide May Improve Disordered Eating Symptoms in Adults Treating Obesity Bioengineer.org
Cheaper semaglutide is in India, but experts want more proof of long-term heart and kidney benefits Firstpost
Get the skinny on GLP-1 safety Association of Health Care Journalists
On a GLP-1 This Holiday? How to Enjoy the Big Feast Without Side Effects U.S. News & World Report
FDA Mandates New Warning Labels on Ozempic and Wegovy Over Rare Vision Loss Risk The Hype Magazine
FDA's NAION Warning Affects Who May Qualify for a GLP-1 Vision Loss Claim JD Supra
GLP-1 vision warning: Could demand be affected? FoodNavigator.com
FDA Issues NAION Warning Across GLP-1 Drug Class As Lilly Expands Zepbound Access Through Hims & Hers London Insider
Health Canada Approves Eli Lilly Foundayo Weight Loss Pill cwibc.co.id
Health Canada approves Eli Lilly’s daily Foundayo pill for weight loss and Type 2 diabetes SSBCrack
$1,000 Invested in Eli Lilly 10 Years Ago Would Be Worth a Fortune Today 24/7 Wall St.
Health Canada approves Eli Lilly's GLP-1 pill for weight loss Castanet
News articles are aggregated from third-party RSS feeds. GLP-1 Check does not endorse or verify individual articles. Content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any treatment.